Cryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression
- Authors:
- Ying Zhang
- Stephanie M. Cabarcas
- Ji Zheng
- Lei Sun
- Lesley A. Mathews
- Xiaohu Zhang
- Hongsheng Lin
- William L. Farrar
-
Affiliations: Cancer Stem Cell Section, Laboratory of Cancer Prevention, National Cancer Institute‑Frederick, Center for Cancer Research, Frederick, MD 21702, USA - Published online on: April 15, 2016 https://doi.org/10.3892/ol.2016.4444
- Pages: 3803-3812
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Harris MA, Yang H, Low BE, Mukherjee J, Guha A, Bronson RT, Shultz LD, Israel MA and Yun K: Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res. 68:10051–10059. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Haraguchi N, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Sasaki A and Mori M: Cancer stem cells in human gastrointestinal cancers. Hum Cell. 19:24–29. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kondo T, Setoguchi T and Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature. 432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Wicha MS, Liu S and Dontu G: Cancer stem cells: An old idea-a paradigm shift. Cancer Res. 66:1883–1890; discussion 1895–1896. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature. 414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Sharifi N, Gulley JL and Dahut WL: Androgen deprivation therapy for prostate cancer. JAMA. 294:238–244. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Sharifi N, Hurt EM and Farrar WL: Androgen receptor expression in prostate cancer stem cells: Is there a conundrum? Cancer Chemother Pharmacol. 62:921–923. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB and Farrar WL: CD44+ CD24(−) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer. 98:756–765. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Duhagon MA, Hurt EM, Sotelo-Silveira JR, Zhang X and Farrar WL: Genomic profiling of tumor initiating prostatospheres. BMC Genomics. 11:3242010. View Article : Google Scholar : PubMed/NCBI | |
|
Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T, Thomas SB and Farrar WL: Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis. 26:433–446. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Dean M, Fojo T and Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Yu S, Li N and Lv J: Investigation of the use of Chinese medicine in patients with malignant conditions. Zhong Guo Zhong Yi Yao Xin Xi Za Zhi. 17:1–3. 2010.(In Chinese). | |
|
Smith M and Boon HS: Counseling cancer patients about herbal medicine. Patient Educ Couns. 38:109–120. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Lin HS and Zhang Y: Evidence-based medical study of TCM on no small cell lung cancer. Shi Jie Ke Xue Ji Shu-Zhong Yi Yao Xian Dai Hua Za Zhi. 10:121–125. 2008.(In Chinese). | |
|
Yang YF, Ge JZ, Wu Y, Xu Y, Liang BY, Luo L, Wu XW, Liu DQ, Zhang X, Song FX and Geng ZY: Cohort study on the effect of a combined treatment of traditional Chinese medicine and western medicine on the relapse and metastasis of 222 patients with stage I and III colorectal cancer after radical operation. Chin J Integr Med. 14:251–256. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao L, Yan S and Jiang T: Inhibitory effect of liuwei dihuang decoction on induced mutation and spontaneous tumor. Zhong Xi Yi Jie He Za Zhi. 10:433–435. 1990.(In Chinese). PubMed/NCBI | |
|
Liang JT, Yan CY, Wang SF, Wu G and Wen PG: Experimental cancer research Liuwei Dihuang Wan prevention. Zhong Yi Za Zhi. 6:71–74. 1983.(In Chinese). | |
|
He XX, Yan C and Endi W: The analysis of the cyto-diagnosis results of liuweidihuangwan treating esophagel precancerous disease and gastric precancerous disease. Hebei Yiyao. 9:4–6. 1998.(In Chinese). | |
|
Zhang Y and Lin HS: Tumor stem cells may be the final target of traditional Chinese medicine in preventing cancer recurrence and metastasis. Zhongguo Zhong Xi Yi Jie He Za Zhi. 29:461–463. 2009.(In Chinese). PubMed/NCBI | |
|
Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS and Jordan CT: The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood. 105:4163–4169. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Kawasaki BT, Hurt EM, Kalathur M, Duhagon MA, Milner JA, Kim YS and Farrar WL: Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach. Prostate. 69:827–837. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Zhang T, Korkaya H, Liu S, Lee HF, Newman B, Yu Y, Clouthier SG, Schwartz SJ, Wicha MS and Sun D: Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res. 16:2580–2590. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Volate SR, Kawasaki BT, Hurt EM, Milner JA, Kim YS, White J and Farrar WL: Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells. Mol Cancer Ther. 9:461–470. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Stickel F, Brinkhaus B, Krähmer N, Seitz HK, Hahn EG and Schuppan D: Antifibrotic properties of botanicals in chronic liver disease. Hepatogastroenterology. 49:1102–1108. 2002.PubMed/NCBI | |
|
Zhou L, Chow M and Zuo Z: Improved quality control method for Danshen products-consideration of both hydrophilic and lipophilic active components. J Pharm Biomed Anal. 41:744–750. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Peng ZS, Rao RS, Ni YW, Tan YS and Gong ZF: Hepatic artery blood medicine treatment of advanced liver cancer efficacy. Zhong Xi Yi Jie He Za Zhi. 13:330–332. 1993.(In Chinese). | |
|
Zhang X, Liu ZH, Liu Y, Zhang ZH, Wan CC, Xia YJ, Jiang Z, Jin YJ, Wang YW and Lu GQ: The effect of compound prescription salvia miltiorrhiza inoculation fluid (CPSMIF) in the treatment of leukemia patients combined with acute tumor dissolution synthesis (ATDS). Xian Dai Zhong Liu Yi Xue Za Zhi. 18:1204–1206. 2010.(In Chinese). | |
|
Kim SY, Moon TC, Chang HW, Son KH, Kang SS and Kim HP: Effects of tanshinone I isolated from salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses. Phytother Res. 16:616–620. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Ng TB, Liu F and Wang ZT: Antioxidative activity of natural products from plants. Life Sci. 66:709–723. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Sung HJ, Choi SM, Yoon Y and An KS: Tanshinone IIA, an ingredient of salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3. Exp Mol Med. 31:174–178. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Gong Y, Li Y, Lu Y, Li L, Abdolmaleky H, Blackburn GL and Zhou JR: Bioactive tanshinones in salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice. Int J Cancer. 129:1042–1052. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Park IJ, Kim MJ, Park OJ, Park MG, Choe W, Kang I, Kim SS and Ha J: Cryptotanshinone sensitizes DU145 prostate cancer cells to Fas(APO1/CD95)-mediated apoptosis through Bcl-2 and MAPK regulation. Cancer Lett. 298:88–98. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Shin DS, Kim HN, Shin KD, Yoon YJ, Kim SJ, Han DC and Kwon BM: Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells. Cancer Res. 69:193–202. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Hur JM, Shim JS, Jung HJ and Kwon HJ: Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitro. Exp Mol Med. 37:133–137. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Z, Zheng J and Xu W: Study on the effect of ofloxacin and tanshinone IIA on human leukocyte chemotactic migration in vitro. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 19:232–235. 1997.(In Chinese). PubMed/NCBI | |
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Tay Y, Zhang J, Thomson AM, Lim B and Rigoutsos I: MicroRNAs to Nanog, OCT4 and SOX2 coding regions modulate embryonic stem cell differentiation. Nature. 455:1124–1128. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Funayama N, Fagotto F, McCrea P and Gumbiner BM: Embryonic axis induction by the armadillo repeat domain of beta-catenin: Evidence for intracellular signaling. J Cell Biol. 128:959–968. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Li L and Neaves WB: Normal stem cells and cancer stem cells: The niche matters. Cancer Res. 66:4553–4557. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, Samira S, Kollet O, Hershkoviz R, Alon R, Hardan I, et al: CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood. 103:2981–2989. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Ehtesham M, Mapara KY, Stevenson CB and Thompson RC: CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett. 274:305–312. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL and Yu JS: Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer. 5:672006. View Article : Google Scholar : PubMed/NCBI | |
|
Salmaggi A, Boiardi A, Gelati M, Russo A, Calatozzolo C, Ciusani E, Sciacca FL, Ottolina A, Parati EA, La Porta C, et al: Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia. 54:850–860. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, et al: Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene. 28:3949–3959. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ and Mongan NP: Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4 and COX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAS. Stem Cells Dev. 18:1093–1108. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Niwa H, Miyazaki J and Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 24:372–376. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Chew JL, Loh YH, Zhang W, Chen X, Tam WL, Yeap LS, Li P, Ang YS, Lim B, Robson P and Ng HH: Reciprocal transcriptional regulation of Pou5f1 and SOX2 via the OCT4/SOX2 complex in embryonic stem cells. Mol Cell Biol. 25:6031–6046. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, Ng HH and Robson P: Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem. 280:24731–24737. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT and Ying SY: Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA. 14:2115–2124. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Wilson KD, Venkatasubrahmanyam S, Jia F, Sun N, Butte AJ and Wu JC: MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev. 18:749–758. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Esquela-Kerscher A and Slack FJ: Oncomirs-MicroRNAS with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et al: A MicroRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Oka Y, Nakajima K, Nagao K, Miura K, Ishii N and Kobayashi H: 293FT cells transduced with four transcription factors (OCT4, SOX2, NANOG and LIN28) generate aberrant ES-like cells. J Stem Cells Regen Med. 6:149–156. 2010.PubMed/NCBI | |
|
Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS and Wu CW: Coexpression of OCT4 and nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Field M, Alvarez A, Bushnev S and Sugaya K: Embryonic stem cell markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients. Clin Neurosurg. 57:151–159. 2010.PubMed/NCBI | |
|
Kléber M and Sommer L: Wnt signaling and the regulation of stem cell function. Curr Opin Cell Biol. 16:681–687. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Weidt C, Niggemann B, Kasenda B, Drell TL, Zänker KS and Dittmar T: Stem cell migration: A quintessential stepping stone to successful therapy. Curr Stem Cell Res Ther. 2:89–103. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Chang L and Karin M: Mammalian MAP kinase signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Cronin PA, Wang JH and Redmond HP: Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4. BMC Cancer. 10:2252010. View Article : Google Scholar : PubMed/NCBI | |
|
Onoue T, Uchida D, Begum NM, Tomizuka Y, Yoshida H and Sato M: Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int J Oncol. 29:1133–1138. 2006.PubMed/NCBI |
